A complete guide to next-generation sequencing: the chemistry behind major platforms, how libraries are built, data analyzed, ...
Explore how rapid next-generation sequencing (NGS) is transforming precision oncology by providing timely molecular profiling ...
Background Next-generation sequencing of cancer predisposition genes is routinely used in hereditary cancer diagnostics.
Newspoint on MSN
Rebuilding Genomics Workflows Around Long-Read Sequencing
Short-read sequencing built the modern genomics era. Illumina platforms, generating millions of short DNA fragments in ...
GenXys and Children’s Colorado are advancing pediatric precision medicine through clinical intelligence and prescribing ...
Four recent breakthroughs in proteomics that are changing the way we sequence, synthesize and discover proteins.
Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant™ System have begun in North America.
The global clinical laboratory services market was valued at USD 274.6 billion in 2025 and is forecast to reach USD 468.2 billion by 2036, rising from USD 298.4 billion in 2026 at a 4.6% CAGR. Growth ...
This routine divestment occurred as the stock reflected a -27% return over the 12 months ending August 14, before a major stock surge. Chicago-based Tempus AI operates a healthcare technology platform ...
On July 16, 2026, the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) ...
The global market is projected to reach $307.9 billion by 2030 at a 6.5% CAGR, as rising cancer incidence, digital pathology, ...
Dr. Céline Vandamme discusses how next-generation BCDTs are changing autoimmune disease treatment, and why high-sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results